Matthew B. Jensen, MD Print Friendly PageFaculty, University of Wisconsin School of Medicine and Public Health
Dr. Jensen, is an assistant professor of neurology at the University of Wisconsin School of Medicine and Public Health. He completed his neurology residency at the University of Iowa and finished his stroke fellowship at the University of California-San Diego. Dr. Jensen is part of the UW Health Comprehensive Stroke Program and his special interests include clinical research of acute stroke and stroke prevention and translational research of cell therapy for stroke.
|Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.|
UW School of Medicine and Public Health
|Department of Neurology|
Professional Certifications and Education
University of Iowa Hospital and Clinics, Iowa City
University of Utah
University of Iowa, Iowa City, IA, 2001
Russek NS Jensen MB .
Histological quantification of brain tissue inflammatory cell infiltration after focal cerebral infarction: a systematic review. Int J Neurosci. 2014 Mar;124(3):160-5
[PubMed ID: 23991681]
Jensen MB Sattar A Al Sherbini K .
Survey of prophylactic antiseizure drug use for non-traumatic intracerebral hemorrhage. Neurol Res. 2013 Nov;35(9):984-7
[PubMed ID: 23582711]
Ostergaard PJ Jensen MB .
Histological quantification of astrocytosis after cerebral infarction: a systematic review. Int J Neurosci. 2013 Jul;123(7):439-43
[PubMed ID: 23311713]
Jensen MB Yan H Krishnaney-Davison R Al Sawaf A Zhang SC .
Survival and differentiation of transplanted neural stem cells derived from human induced pluripotent stem cells in a rat stroke model. J Stroke Cerebrovasc Dis. 2013 May;22(4):304-8
[PubMed ID: 22078778]
Leung WY Jensen MB .
Histological quantification of angiogenesis after focal cerebral infarction: a systematic review. ISRN Neurol. 2013;2013:853737
[PubMed ID: 24490083]
Reddig RT Nixdorf KE Jensen MB .
The prophylactic use of an antiepileptic drug in intracerebral hemorrhage. Clin Neurol Neurosurg. 2011 Dec;113(10):895-7
[PubMed ID: 21824722]
Jensen MB Han DY Sawaf AA Krishnaney-Davison R .
Behavioral outcome measures used for human neural stem cell transplantation in rat stroke models. Neurol Int. 2011 Jul 5;3(2):e10
[PubMed ID: 22053257]
Jensen MB .
The Accountant Who Lost Arithmetic: A Case Report of Acalculia With a Left Thalamic Lesion. J Med Cases. 2010 Dec 1;1(3):92-93
[PubMed ID: 21546980]
Sattar A Manousakis G Jensen MB .
Systematic review of reversible cerebral vasoconstriction syndrome. Expert Rev Cardiovasc Ther. 2010 Oct;8(10):1417-21
[PubMed ID: 20936928]
Jensen MB Chacon MR Sattin JA Levine RL Vemuganti R .
Potential biomarkers for the diagnosis of stroke. Expert Rev Cardiovasc Ther. 2009 Apr;7(4):389-93
[PubMed ID: 19379063]
Manousakis G Jensen MB Chacon MR Sattin JA Levine RL .
The interface between stroke and infectious disease: infectious diseases leading to stroke and infections complicating stroke. Curr Neurol Neurosci Rep. 2009 Jan;9(1):28-34
[PubMed ID: 19080750]
Jensen MB Chacon MR Sattin JA Aleu A Lyden PD .
The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack. Neurologist. 2008 Jul;14(4):243-6
[PubMed ID: 18617850]